Document is current
Any future updates will be listed below
-
Authors
Ofori, Edward
Vaillancourt, David E.
Greig-Custo, Maria T
Barker, Warren
Hanson, Kevin
DeKosky, Steven T.
Garvan, Cynthia S.
Adjouadi, Malek
Golde, Todd
Loewenstein, David A.
Stecher, Chad
Fowers, Rylan
Duara, Ranjan
-
Funding
Funding for this research was provided by:
National Institute of Health
- License Information
-
More Information
Article History
Accepted: 22 October 2023
First Online: 31 October 2023
Declarations
:
: Edward Ofori – none, David E. Vaillancourt – Reports grants from NIH, NSF, Tyler’s Hope Foundation during the conduct of the study, and honoraria from NIH and Parkinson Foundation unrelated to the submitted work. He is a co-founder of Neuroimaging Solutions. Maria T. Greig-Custo – none, Warren Barker – none, Steven T. DeKosky – reports receiving consultation funds as member of the Neuroscience Advisory Board for Amgen; Chair of DSMB for Biogen; Chair, Medical Advisory Board for Cognition Therapeutics, Kevin Hanson – none, Cynthia Garvan – none, Malek Adjouadi –none, Todd Golde – receives grant support from NIH, Michael J. Fox Foundation, Ellison Medical Foundation, and Thome Foundation, David Loewenstein – none, Chad Stecher – none, Rylan Fowers – none, Ranjan Duara –receives grant support from Alzheimer’s Therapeutic Research Institute, Avid-Eli Lily & Company, Janssen Research & Development LLC, Merck & Company, Toyama Chemical Co., Ltd, and vTv Therapeutics LLC. Dr. Duara also serves as a consultant for Medical Learning Group.
: The use of human subject data was approved by Mount Sinai and University of Florida IRB. All participants consented to the protocol and publish findings.
